Palantir Stock (PLTR) Is a ‘Winner,’ Says Piper Sandler

Piper Sandler has initiated coverage of Palantir (PLTR) with an Overweight rating and a $170 price target, citing its position as an "AI All-Star" and a "secular winner" poised for 30% growth. Analyst Brent Bracelin anticipates PLTR will benefit from deepening defense ties and robust U.S. commercial revenue growth, projecting a 33% CAGR to $5 billion by 2030. This bullish outlook comes despite PLTR's current high valuation (PE of 694) and a prevailing Wall Street consensus of "Hold" with an average price target implying significant downside risk.

Analysis

A significant divergence in sentiment surrounds Palantir (PLTR), highlighted by Piper Sandler's newly initiated coverage with a bullish Overweight rating and a $170 price target. This optimistic outlook contrasts sharply with the broader Wall Street consensus, which holds a "Hold" rating from 17 analysts and an average price target of $109.50, implying a 31.12% downside risk. Piper Sandler's analyst, Brent Bracelin, positions PLTR as a "secular winner in the AI revolution," forecasting another 30% upside. The bull thesis is underpinned by two key drivers: deepening ties with the U.S. military and a projected 33% compound annual growth rate (CAGR) in U.S. commercial revenue, potentially reaching $5 billion by 2030. This projection is supported by a 144% surge in website visitor traffic in the second quarter. However, this bullish stance is taken in the context of a stock that has already appreciated 110% this year, resulting in a lofty price-to-earnings ratio of 694, indicating that high growth expectations are already priced in.

Key Decisions for Investors

• Investors should weigh Piper Sandler's high-conviction bull case, driven by specific long-term AI and commercial growth forecasts, against the prevailing cautious market consensus and its implied downside, recognizing the position as a high-risk, high-reward outlier view.
• Given the stock's 110% year-to-date run-up and a P/E ratio of 694, it is critical to scutinize the company's execution on both its government and commercial contracts to validate this premium valuation in upcoming quarters.
• Consider monitoring leading indicators such as website traffic growth and announcements of new commercial or defense partnerships as potential validation for the aggressive growth thesis ahead of formal earnings reports.